Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Nabelin Fuji Science Ties Up with 2 Medical Devices Wholesalers
April 15, 2002
- REGULATORY NEWS IN BRIEF
April 15, 2002
- Oticon: New Hearing Aid Adapto
April 15, 2002
- BULLETIN
April 15, 2002
- Medical Institutions Can Advertise from April 1
April 15, 2002
- Let the Change Be Your Friend: Mr Ogawa of Nippon Roche
April 15, 2002
- Yamanouchi to Nearly Achieve 6% Market Share: President Takenaka
April 8, 2002
- FY2002 Budget Approved by Diet
April 8, 2002
- Takeda Subscribes to Gene Logic's Gene Expression Database
April 8, 2002
- REGULATORY NEWS IN BRIEF
April 8, 2002
- Sankyo Transfers Development of Glaucoma Drug to Santen
April 8, 2002
- Elimination of Prescription Period Limitation Should Help Bungyo : Expert
April 8, 2002
- Nippon Shinyaku to Market HIGA Mice via Japan SLC
April 8, 2002
- Final Draft GL for Acute Pancreatitis Presented by JSAEM
April 8, 2002
- Otsuka, Otsuka Pharm Factory, Snow Brand Milk Create JV for Clinical Nutrition
April 8, 2002
- Korosho to Construct Critical Path-Sharing System
April 8, 2002
- Major Maker's New Invoice Prices Are More Acceptable than Before: Suzuken
April 8, 2002
- Doctors' Participation in Clinical Trial Training Disappointing
April 8, 2002
- BUSINESS NEWS IN BRIEF
April 8, 2002
- RESEARCH AND DEVELOPMENT NEWS IN BRIEF
April 8, 2002
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…